In-Vivo Toxicology Market Size, Share, Sales, Analysis, Forecast, Industry Competition & Player Profiles 2023 - 2032
Market Likely to Reach Near $7 bn in Valuation as R&D Spending Soars
The global in vivo toxicology market will likely witness significant growth during 2023-2032, as research spending for coronavirus vaccination, and demand for animal testing witness a sharp increase. According to the World Health Organization, over 172 countries have joined initiatives to further research for coronavirus vaccine.
Among these, are potentially 80 countries which will be self-financing the development of vaccines. Moreover, the development of technologies like augmented reality will also further efficacy of research, and boost prospects of animal testing in the near future.
Growth of Oncology Remains a Key Prospect for Growth
According to the World Health Organization, Cancer leads the global toll of deaths, resulting in nearly 10 million deaths in 2018. Moreover, the several forms of cancer including prostate, lung, stomach, liver, and colorectal cancers continue to plague urban populations globally. The rising sedentary lifestyle, worsening environmental conditions, and in-take of unhealthy fast foods will likely exacerbate the crisis among emerging countries in the near future.
However, the rise in research and development spending for cancer detection, diagnosis, and prevention, and expansion of the healthcare facilities will provide impetus for growth in emerging nations. Moreover, rise in awareness for issues like breast cancer, and growth of personalized medicines, and positive attitude of the FDA towards emerging therapies will also result in substantial growth for the vivo toxicology market in the near future.
Cell Culture Technology Will Likely Dominate Market Growth
The cell culture technology remains at the forefront of major scientific breakthroughs in the vivo-toxicology market. The technology is known for its small molecule based minimal culture environments, which promises precise control to cater to complex research demands. Moreover, the technology also enables nutritional and physiochemical demands, which have received limited attention in past research queries.
Furthermore, the technology also enables environment to study industrial bioprocesses, which remain a new arena for growth for players in the vivo toxicology market. The rising demand for cell culture technology, its tremendous lead in breakthrough and research spending, and technological developments like 3D cell culture will remain key factors for its growth.
The Chronic Toxicity Segment Will Register Highest Revenues
The in vivo toxicology market is segmented into chronic, sub-chronic, sub-acute, and acute toxicology, based on the testing type. The market will likely register highest revenues in chronic toxicology, as increased investments in drug development, rising promise of commercialization in developing countries, and promising road-path from the FDA towards development of drugs for rare diseases will drive major growth for the segment.
The segment also caters to some chronic illnesses, leading the cause of deaths worldwide including cancer, arthritis, among others. Arthritis as part of musculoskeletal conditions leads the economic loss among workforce in the US, with losses accumulating to over $200 bn in 2019.
The in-vivo toxicology market report is also divided into in-house, and outsourced testing facilities. Among these, the outsourcing facilities will likely register highest growth, thanks to emerging collaboration, and research opportunities in developed nations. The outsourcing will also lead to major cost-saving, pushing growth further for players in the in-vivo toxicology market.
The In-Vivo Toxicology Market is Segmented as Below:
By Product
- Consumables
- Reagents & Kits
- Animal Models
- Mice Models
- Rat Models
- Other Animal Models
- Instruments
By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
By Toxicity Endpoint
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity (DART)
- Other Toxicity Endpoints
By Region
- North America
- United States
- Canada
- Rest of North America
- Europe
- Germany
- United Kingdom
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- India
- China
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- South America
- Brazil
- Rest of South America
